NCT01623622View on ClinicalTrials.gov

Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Severe Upper Limb Hemiplegia
Interventions
DRUG

HC-58

once or more / week

DRUG

Placebo

once or more / week

Trial Locations (3)

Unknown

Fukui-shi

Hamamatsu

Kumamoto, Kumamoto

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT01623622 - Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke | Biotech Hunter | Biotech Hunter